News
BCPC
139.03
-1.14%
-1.61
Balchem Corporation's (NASDAQ:BCPC) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Balchem (NASDAQ:BCPC) has a 10% return on equity of 10%. Balchem's net income growth is 7.5% over the past five years. The company's ROE is a measure of how efficiently a company can generate profits. Balchem has a decent ROE of 10%, compared to the industry average of 13%. The company has been down 7.8% in the past month.
Simply Wall St · 3d ago
Weekly Report: what happened at BCPC last week (0415-0419)?
Weekly Report · 3d ago
Balchem Corporation Releases 2023 Sustainability Report
Barchart · 3d ago
Balchem Corporation Announces Quarterly Conference Call for First Quarter Financial Results on May 3, 2024
Balchem Corporation will hold a conference call on May 3, 2024, to review first quarter results. Ted Harris, Chairman of the Board, President and CEO, and Martin Bengtsson will host the call. The conference call will be held at 11:00 a.m. ET.
Barchart · 6d ago
Weekly Report: what happened at BCPC last week (0408-0412)?
Weekly Report · 04/15 09:29
Weekly Report: what happened at BCPC last week (0401-0405)?
Weekly Report · 04/08 09:31
Balchem (NASDAQ:BCPC) shareholders have earned a 10% CAGR over the last five years
The Balchem Corporation's share price is up 57% in the last five years, but that's less than the market return. Balchem shareholders gained a total return of 21% during the year. The company has grown its earnings per share at 6.6% a year, slower than the average growth of 9%. Balchem may not be the best stock to buy.
Simply Wall St · 04/05 11:01
Weekly Report: what happened at BCPC last week (0325-0329)?
Weekly Report · 04/01 09:30
Balchem Finance Chief Bengtsson to Oversee Animal Nutrition and Health Segment
Balchem expanded Chief Financial Officer C. Martin Bengtsson's responsibilities to include leadership of the animal nutrition and health segment. The company also disclosed that Jonathan Griffin is moving into the role of senior vice president. Balchem provides marketing of specialty performance ingredients and products .
Dow Jones · 03/29 21:09
Balchem Corp Executive Roles Shift and Expand Responsibilities
Balchem Corp. Has recently made significant executive role changes. Jonathan H. Griffin transitioning to Senior Vice President of Corporate Development. C. Martin Bengtsson extends his purview to include the Animal Nutrition and Health segment. Both executives maintain their current compensation despite the changes.
TipRanks · 03/29 20:32
Blachem (BCPC) Is a Great Choice for 'Trend' Investors, Here's Why
NASDAQ · 03/28 12:50
Weekly Report: what happened at BCPC last week (0318-0322)?
Weekly Report · 03/25 09:31
Balchem Corporation's (NASDAQ:BCPC) Popularity With Investors Is Clear
Balchem Corporation has a price-to-earnings ratio of 46.6x. The company's P/E is higher than the majority of companies in the U.S. Balchem's earnings growth has been positive and investors are willing to pay more for the stock. The high P/e ratio may be due to the company's superior earnings growth outlook.
Simply Wall St · 03/21 10:56
Time to Buy These Top-Rated Basic Materials Stocks Amid an Uptick in Inflationary Data
NASDAQ · 03/18 20:16
The Zacks Analyst Blog Highlights Atmos Energy, Balchem, Cardinal Health, Casey's and Colgate-Palmolive
NASDAQ · 03/18 12:35
Weekly Report: what happened at BCPC last week (0311-0315)?
Weekly Report · 03/18 09:31
5 Low-Beta Stocks for Safe Returns as Inflation Rises Again
NASDAQ · 03/15 12:32
Here's Why Momentum in Blachem (BCPC) Should Keep going
NASDAQ · 03/11 12:50
Weekly Report: what happened at BCPC last week (0304-0308)?
Weekly Report · 03/11 09:30
Is Balchem Corporation (NASDAQ:BCPC) Expensive For A Reason? A Look At Its Intrinsic Value
Balchem Corporation (NASDAQ:BCPC) is estimated to be 26% overvalued at its current share price of US$157. Balchem's estimated fair value is US$125 based on 2 Stage Free Cash Flow to Equity. We will use a Discounted Cash Flow model to estimate the value of Balchem Corporation. The company is projected to be worth around US$4.7b in the future.
Simply Wall St · 03/05 11:51
More
Webull provides a variety of real-time BCPC stock news. You can receive the latest news about Balchem Corp through multiple platforms. This information may help you make smarter investment decisions.
About BCPC
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. The Company's segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. Through Specialty Products, it re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.